---
category: news
title: "IPO Launch: Renalytix AI Proposes U.S. IPO Terms"
excerpt: "Cardiff, UK-based Renalytix was founded to create an artificial intelligence-based diagnostics system for kidney and potentially other chronic disease conditions. Management"
publishedDateTime: 2020-07-14T16:33:00Z
webUrl: "https://www.thestreet.com/ipo/news/renalytix-ai-ipo-launch"
ampWebUrl: "https://www.thestreet.com/.amp-ipo/ipo/news/renalytix-ai-ipo-launch"
cdnAmpWebUrl: "https://www-thestreet-com.cdn.ampproject.org/c/s/www.thestreet.com/.amp-ipo/ipo/news/renalytix-ai-ipo-launch"
type: article
quality: 57
heat: -1
published: false

provider:
  name: TheStreet.com
  domain: thestreet.com

topics:
  - AI

images:
  - url: "https://www.thestreet.com/.image/c_fit%2Ccs_srgb%2Cq_auto:good%2Cw_620/MTczOTYyMDYyMDM1MTY3MDk5/renalytixnamarket.png"
    width: 620
    height: 357
    isCached: true

related:
  - title: "Kidney diagnostics developer Renalytix AI sets terms for $78 million US IPO"
    excerpt: "Renalytix AI, which is commercializing AI-powered diagnostic tests for kidney disease, announced terms for its IPO on Monday. The Cardiff, United Kingdom-based company plans to raise $78 million by offering 5.5 million ADSs at $14.22, the as-converted last ..."
    publishedDateTime: 2020-07-13T15:10:00Z
    webUrl: "https://www.nasdaq.com/articles/kidney-diagnostics-developer-renalytix-ai-sets-terms-for-%2478-million-us-ipo-2020-07-13"
    ampWebUrl: "https://www.nasdaq.com/articles/kidney-diagnostics-developer-renalytix-ai-sets-terms-for-%2478-million-us-ipo-2020-07-13?amp"
    cdnAmpWebUrl: "https://www-nasdaq-com.cdn.ampproject.org/c/s/www.nasdaq.com/articles/kidney-diagnostics-developer-renalytix-ai-sets-terms-for-%2478-million-us-ipo-2020-07-13?amp"
    type: article
    provider:
      name: Nasdaq
      domain: nasdaq.com
    quality: 65

secured: "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;EAB9cliSb3eC8pNjNBFA3w=="
---

